Nephros, Inc. (NEPH)
3.89
+0.07
(+1.83%)
USD |
NASDAQ |
Mar 05, 16:00
3.91
+0.02
(+0.51%)
Pre-Market: 20:00
Nephros Cash from Investing (TTM) : 0.00 for Sept. 30, 2025
Cash from Investing (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (TTM) Benchmarks
| Apyx Medical Corp. | -1.024M |
| Cerus Corp. | -6.165M |
| Owlet, Inc. | -0.493M |
| Abbott Laboratories | -2.422B |
| Plus Therapeutics, Inc. | 0.287M |